ABSTRACT
I. Introduction With improved survival among individuals with cystic fibrosis (CF), diabetes mellitus has emerged as a significant comorbidity. While much of its pathophysiology overlaps that of both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), cystic fibrosis-related diabetes (CFRD) is considered a distinct form of diabetes. An important distinction clinically is the management approach, which is tailored to meet the unique medical needs of the individual with CF.
